Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 Injection in participants with chronic hepatitis B, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137 injection (AHB-137)

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: NOT_YET_RECRUITING